|
EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor
|
CHEBI_78377 |
|
|
EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor
|
CHEBI_78379 |
|
|
isobaric labeling
|
ERO_0002176 |
|
|
protein abundance method
|
BAO_0040014 |
|
|
chloride transport
|
GO_0006821 |
|
|
EC 3.2.1.169 (protein O-GlcNAcase) inhibitor
|
CHEBI_234036 |
|
|
EC 3.1.1.5 (lysophospholipase) inhibitor
|
CHEBI_78372 |
|
|
pancreas
|
UBERON_0001264 |
[Organ which secretes a fluid containing enzymes that aid in the digestion of food.[AAO]] |
|
microcystic adenoma
|
DOID_5403 |
|
|
bacterial infection method
|
BAO_0000547 |
|
|
pathogenic virus transduction method
|
BAO_0000546 |
|
|
recombinant virus transduction method
|
BAO_0000545 |
|
|
esiRNA
|
BAO_0000544 |
|
|
orthogonal assay design
|
BAO_0000543 |
|
|
schizophrenia
|
DOID_5419 |
|
|
EC 5.1.2.* (racemases acting on hydroxy acids and derivatives) inhibitor
|
CHEBI_78381 |
|
|
EC 3.5.4.1 (cytosine deaminase) inhibitor
|
CHEBI_78380 |
|
|
EC 5.1.99.* (racemases acting on other compounds) inhibitor
|
CHEBI_78383 |
|
|
EC 5.1.3.* (racemases acting on carbohydrates and derivatives) inhibitor
|
CHEBI_78382 |
|
|
EC 5.1.3.2 (UDP-glucose 4-epimerase) inhibitor
|
CHEBI_78384 |
|
